Advertisement

Pharmaceutical Chemistry Journal

, Volume 35, Issue 5, pp 235–238 | Cite as

Actoprotector and Adaptogen Properties of Adamantane Derivatives (A Review)

  • I. S. Morozov
  • I. A. Ivanova
  • T. A. Lukicheva
Article

Keywords

Organic Chemistry Adamantane Adamantane Derivative Adaptogen Property 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    A. V. Smirnov, Antihypoxants and Actoprotectors: Developments and Prospects [in Russian], St. Petersburg Military-Medical Academy, St. Petersburg (1994), Issue III, p. 164.Google Scholar
  2. 2.
    A. V. Smirnov and V. M. Vinogradov, Antihypoxants and Actoprotectors: Developments and Prospects [in Russian], St. Petersburg Military-Medical Academy, St. Petersburg (1994), Issue III, p. 165.Google Scholar
  3. 3.
    I. I. Brekhman, The Pharmacology of Motor Activity [in Russian], Nauka, Moscow (1969), pp. 9–26.Google Scholar
  4. 4.
    N. V. Lazarev, E. I. Lyublina, and M. A. Rozin, Patol. Fiziol. Eksp. Terap., No. 4, 16–21 (1959).Google Scholar
  5. 5.
    A. D. Turova, Medicinal Plants of the USSR and Their Use [in Russian], Meditsina, Moscow (1974).Google Scholar
  6. 6.
    R. D. Seifulla, Sport Pharmacology [in Russian], Moskovskaya Pravda, Moscow (1999).Google Scholar
  7. 7.
    I. E. Kovalev, Khim.-Farm. Zh., 11(3), 19–27 (1977).Google Scholar
  8. 8.
    I. S. Morozov, V. I. Petrov, and S. A. Sergeeva, The Pharmacology of Adamantanes [in Russian], Volgograd State Medical Academy, Volgograd (2001).Google Scholar
  9. 9.
    N. G. Artsimovich, T. S. Galushina, and T. A. Fadeeva, Int. J. Immunorheab., 2(1), 54–60 (2000).Google Scholar
  10. 10.
    A. A. Spasov, T. V. Khamidova, L. I. Bugaeva, and I. S. Morozov, Khim.-Farm. Zh., 34(1), 3–9 (2000).Google Scholar
  11. 11.
    K. W. Lange, W. Brikmayer, and P. Riederer, New Trends. Clin. Neuropharmacol., 6(1 - 4), 37–41 (1992).Google Scholar
  12. 12.
    J. Kornhuber, M. Weller, K. Schoppmeyer, and P. Riederer, J. Neural. Transm., Suppl. 43, 91–104 (1994).Google Scholar
  13. 13.
    J. Kornuber and M. Weller, Biol. Psychiatry, 41(2), 139–144 (1997).Google Scholar
  14. 14.
    V. I. Petrov, L. B. Piotrovskii, and I. A. Grigor'ev, Exciting Amino Acids: Neurochemistry, Pharmacology, and Therapeutic Potential of EAA-ergic Agents [in Russian], Volgograd State Medical Academy, Volgograd (1997).Google Scholar
  15. 15.
    H. S. Chen and S. A. Lipton, J. Physiol. (London), 499(Pt 1), 27–46 (1997).Google Scholar
  16. 16.
    A. Sobolevsky and S. Koshelev, Biophys. J., 74(3), 1305–1319 (1998).Google Scholar
  17. 17.
    T. A. Blanpied, F. A. Boeckman, E. Aizenman, and J. W. Johnson, J. Neurophysiol., 77(1), 309–323 (1997).Google Scholar
  18. 18.
    J. Kornhuber, K. Shoppmeyer, and P. Riederer, Neurosci. Lett., 163(2), 129–131 (1993).Google Scholar
  19. 19.
    D. Ferger and J. Krieglstein, Brain Res., 732(1 - 2), 87–94 (1996).Google Scholar
  20. 20.
    B. A. Vogels, M. A. Maas, J. Daalhuisen, et al., Hepatology, 25(4), 820–827 (1997) (Medline, 1997).Google Scholar
  21. 21.
    V. A. Markin, Voen.-Med. Zh., No. 8, 51–60 (2000).Google Scholar
  22. 22.
    S. M. Toggas, E. Masliah and L. Mucke, Brain Res., 706(2), 303–307 (1996).Google Scholar
  23. 23.
    I. S. Morozov, E. A. Val'dman, T. A. Voronina, et al., Khim.-Farm. Zh., 34(4), 27–31 (2000).Google Scholar
  24. 24.
    L. N. Nerobkova, E. A. Val'dman, T. A. Voronina, et al., Eksp. Klin. Farmakol., No. 3, 3–6 (2000).Google Scholar
  25. 25.
    V. E. Gmiro and S. E. Serdyuk, Eksp. Klin. Farmakol., No. 3, 16–20 (2000).Google Scholar
  26. 26.
    G. L. Wenk, W. Danysz, and D. D. Roice, Neuroreport., 7(9), 1453–1456 (1996).Google Scholar
  27. 27.
    R. Kakkar, R. V. Raju, A. H. Rajput, and R. K. Sharma, Brain. Res., 749(2), 290–294 (1997).Google Scholar
  28. 28.
    L.-O. Farnebo, K. Fuxe, M. Goldstein, et al., Eur. J. Pharmacol., 16(1), 27–38 (1971).Google Scholar
  29. 29.
    T. W. Stone, Brit. J. Pharmacol., 56(1), 101–110 (1976).Google Scholar
  30. 30.
    V. I. Ratnikov and L. I. Ratnikova. in: Pharmacological Regulation of Deadaptation States [in Russian]. Institute of Pharmacology, Moscow (1986), pp. 74–81.Google Scholar
  31. 31.
    I. S. Morozov, B. M. Pyatin, L. P. Efimova, et al., Abstracts of Papers. The All-Union Conf. “Prospects in the Chemistry of Framework Compounds and Their Use in National Economy” [in Russian], Kuibyshev (1989), p. 104.Google Scholar
  32. 32.
    I. S. Morozov, N. P. Bykov, Sh. Karadzhaev, et al., Abstracts of Papers. The 7th Sci.-Pract. Conf. of CIS Countries “Prospects in Development of the Chemistry and Applications of Framework Compounds” [in Russian], Volgograd (1995), p. 23–24.Google Scholar
  33. 33.
    N. V. Klimova, N. I. Avdyunina, B. M. Pyatin, and I. S. Morozov, Abstracts of Papers. The 7th Sci.-Pract. Conf. of CIS Countries “Prospects in Development of the Chemistry and Applications of Framework Compounds” [in Russian], Volgograd (1995), pp. 140–141.Google Scholar
  34. 34.
    N. M. Zaitseva, I. S. Morozov, N. V. Klimova, et al., USSR Inventor's Certificate No. 782313; Byull. Izobret., No. 43–44 (1993).Google Scholar
  35. 35.
    E. V. Val'dman, N. M. Zaitseva, N. V. Klimova, et al., USSR Inventor's Certificate No. 260446; Byull. Izobret., No. 43–44 (1993).Google Scholar
  36. 36.
    I. S. Morozov, N. V. Klimova, L. N. Lavrova, et al., Khim.-Farm. Zh., 32(1), 3–6 (1998).Google Scholar
  37. 37.
    N. I. Avdyunina, N. V. Klimova, V. I. Kuz'min, et al., USSR Inventor's Certificate No. 1055105; Byull. Izobret., No. 3 (1992).Google Scholar
  38. 38.
    I. S. Morozov, N. I. Avdyunina, N. V. Klimova, et al., “Prospects in Development of the Chemistry and Applications of Framework Compounds [in Russian], Volgograd (1995), pp. 167–168.Google Scholar
  39. 39.
    I. S. Morozov, N. G. Artsimovich, N. V. Klimova, et al., RF Patent No. 1646256 (1991); Byull. Izobret., No. 16 (1996).Google Scholar
  40. 40.
    N. V. Klimova, I. S. Morozov, N. P. Bykov, et al., RF Patent No. 1819416; Byull. Izobret., No. 20 (1993).Google Scholar
  41. 41.
    N. I. Avdyunina, N. V. Klimova, B. M. Pyatin, et al., “Prospects in Development of the Chemistry and Applications of Framework Compounds [in Russian], Volgograd (1995), pp. 168–169.Google Scholar
  42. 42.
    I. S. Morozov, N. G. Artsimovich, T. A. Fadeeva, et al., RF Patent No. 1826906; Byull. Izobret., No. 25 (1993).Google Scholar
  43. 43.
    I. S. Morozov, N. V. Klimova, S. A. Sergeeva, et al., Vesti Ross. Akad. Med. Nauk, No. 3, 28–32 (1990).Google Scholar
  44. 44.
    T. V. Grekhova, R. R. Gainetdinov, T. D. Sotnikova, et al., Byul. Eksp. Biol. Med., No. 3, 302–304 (1995).Google Scholar
  45. 45.
    I. S. Morozov and N. N. Kleimenova, Eksp. Klin. Farmakol., No. 6, 51–53 (1998).Google Scholar
  46. 46.
    T. S. Galushina, T. A. Fadeeva, and N. G. Artsimovich, Immunologiya, No. 4, 28–30 (1996).Google Scholar
  47. 47.
    T. S. Galushina, T. A. Fadeeva, and N. G. Artsimovich, Immunologiya, No. 4, 31–45 (1996).Google Scholar
  48. 48.
    P. V. Vasil'ev, G. D. Glod, and S. I. Sytnik, A Handbook of Aviation Therapist [in Russian), Vozdushnyi Transport, Moscow (1993), Vol. II, pp. 148–160.Google Scholar
  49. 49.
    T. A. Lukicheva, A. V. Sedov, I. S. Morozov, and N. A. Surovtsev, Abstracts of Papers. The 5th All-Russia Congr. “Humans and Drugs” [in Russian], Moscow (1998), p. 448.Google Scholar
  50. 50.
    S. V. Sibiryak, M. G. Davydovich, S. A. Sergeeva, et al., Abstracts of Papers. The 5th All-Russia Congr. “Humans and Drugs” [in Russian], Moscow (1998), p. 524.Google Scholar
  51. 51.
    N. N. Zolotov, S. A. Sergeeva, and S. S. Losev, Abstracts of Papers. The 6th Conf. “Bioantioxidant” [in Russian], Moscow (1993), Vol. I, pp. 20–21.Google Scholar
  52. 52.
    V. A. Myshkin, S. A. Sergeeva, and E. K. Alekhin, Abstracts of Papers. The 4th All-Russia Congr. “Humans and Drugs” [in Russian], Moscow (1997), p. 278.Google Scholar

Copyright information

© Plenum Publishing Corporation 2001

Authors and Affiliations

  • I. S. Morozov
    • 1
  • I. A. Ivanova
    • 1
  • T. A. Lukicheva
    • 2
  1. 1.Russian Academy of Medical Sciences,Institute of Pharmacology,Moscow,Russia.
  2. 2.Ministry of Public Health of the Russian Federation,All-Russia Center for Medicine of Catastrophes,Moscow,Russia.

Personalised recommendations